Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued)
Title:Meet Our Editor:
Volume: 15 Issue: 2
Author(s): Gjumrakch Aliev
Affiliation:
Export Options
About this article
Cite this article as:
Aliev Gjumrakch, Meet Our Editor:, Immunology, Endocrine & Metabolic Agents in Medicinal Chemistry (Discontinued) 2015; 15 (2) . https://dx.doi.org/10.2174/187152221502151013171959
DOI https://dx.doi.org/10.2174/187152221502151013171959 |
Print ISSN 1871-5222 |
Publisher Name Bentham Science Publisher |
Online ISSN 1875-6115 |
Related Books
23
Related Articles
-
Metabolic Syndrome, Mild Cognitive Impairment and Dementia
Current Alzheimer Research Cerebral Amyloid Angiopathy: A Common Cause of Cerebral Hemorrhage
Current Medicinal Chemistry Neuro-Transmitters in the Central Nervous System & their Implication in Learning and Memory Processes
Current Medicinal Chemistry Hyperhomocysteinemia and Cardiovascular Risk: Effect of Vitamin Supplementation in Risk Reduction
Current Clinical Pharmacology Resistin: An Inflammatory Cytokine. Role in Cardiovascular Diseases, Diabetes and the Metabolic Syndrome
Current Pharmaceutical Design C-Reactive Protein: Interaction with the Vascular Endothelium and Possible Role in Human Atherosclerosis
Current Pharmaceutical Design Systematic Review Investigating Multi-disciplinary Team Approaches to Screening and Early Diagnosis of Dementia in Primary Care – What are the Positive and Negative Effects and Who Should Deliver It?
Current Alzheimer Research The Pathophysiology of Heme in the Brain
Current Alzheimer Research Strategies that Target Tight Junctions for Enhanced Drug Delivery
Current Pharmaceutical Design Ethnic and Geographical Differences in Ischaemic Stroke Among Young Adults
Current Vascular Pharmacology Juvenile Systemic Lupus Erythematosus
Current Pediatric Reviews Advances in Drug Delivery from Nose to Brain: An Overview
Current Drug Therapy Small Molecules in Stem Cell Research
Current Pharmaceutical Biotechnology The Diagnostic Value of CSF Amyloid-β<sub>43</sub> in Differentiation of Dementia Syndromes
Current Alzheimer Research Potential Drugs Targeting Microglia: Current Knowledge and Future Prospects
CNS & Neurological Disorders - Drug Targets Endothelial Dysfunction and Coronary Atherosclerosis
Current Drug Targets - Cardiovascular & Hematological Disorders Modifiable Midlife Risk Factors for Late-Life Cognitive Impairment and Dementia
Current Psychiatry Reviews Editorial (Hot Topic: Biomedical Engineering Imaging)
Current Pharmaceutical Biotechnology Silence of the Limbs: Pharmacological Symptomatic Treatment of Intermittent Claudication
Current Vascular Pharmacology The Innate Immunity in Alzheimer Disease- Relevance to Pathogenesis and Therapy
Current Pharmaceutical Design